Clinical Trials for Fate Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Fate Therapeutics

Clinical Trials (5)

NCT07216105
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
PHASE1Recruiting
113 participants
Started: Oct 30, 2025 · Completed: Jan 31, 2030
6 conditions1 sponsor1 location
NCT06308978
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
PHASE1Recruiting
244 participants
Started: Mar 28, 2024 · Completed: Sep 30, 2042
4 conditions1 sponsor9 locations
NCT06241456
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
PHASE1Recruiting
351 participants
Started: Jan 5, 2024 · Completed: May 1, 2044
1 condition1 sponsor15 locations
NCT05182073
FT576 in Subjects With Multiple Myeloma
PHASE1Active, not recruiting
31 participants
Started: Nov 10, 2021 · Completed: Feb 29, 2040
2 conditions1 sponsor14 locations
NCT04629729
FT819 in Subjects With B-cell Malignancies
PHASE1Active, not recruiting
54 participants
Started: Jul 12, 2021 · Completed: Sep 30, 2039
3 conditions1 sponsor17 locations